Salesforce in talks to acquire Listen Labs for $2B

Salesforce is in discussions to buy Listen Labs, an AI-powered customer research startup, for approximately $2 billion. The deal, if completed, would represent a jaw-dropping 4x markup from the company’s $500 million valuation just eight months ago.

Listen Labs was founded in 2023 and has spent its short existence automating the kind of qualitative customer research that traditionally requires rooms full of human interviewers, clipboard-wielding moderators, and weeks of scheduling headaches. Its AI interviewers can design studies, recruit participants from a global network, and conduct the conversations themselves. The company has already run more than 1 million interviews.

A startup growing faster than Salesforce can ignore

Listen Labs reported 15x annualized revenue growth. Its client list includes Microsoft, Anthropic, Google, Perplexity, Nestlé, and Sweetgreen.

In January 2026, Listen Labs raised $69 million in a Series B round at a $500 million valuation. The startup had reportedly signed a term sheet for a $125 million Series C at a $1.5 billion valuation. Then it walked away from the deal. The reason: ongoing acquisition conversations with Salesforce that could deliver a far larger payday for founders and investors alike.

What Salesforce gets out of the deal

At roughly $2 billion, Salesforce would be paying about 67 times Listen Labs’ estimated $30 million in annual revenue. Most enterprise SaaS acquisitions land somewhere between 10x and 20x revenue.

Salesforce has been building out its Agentforce AI platform, a suite of autonomous AI agents designed to handle various enterprise tasks. Listen Labs would plug a specific gap in that vision: understanding what customers actually think.

This would also be Salesforce’s fourth AI-related acquisition in 2026.

The bigger picture for AI acquisitions

The talks remain ongoing, and there’s no guarantee the deal reaches the finish line. Acquisitions at this scale frequently stall over price disagreements, regulatory concerns, or integration disputes.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.